rs59286323

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_021098.3(CACNA1H):​c.4817C>T​(p.Thr1606Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00697 in 1,584,426 control chromosomes in the GnomAD database, including 56 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. T1606T) has been classified as Benign.

Frequency

Genomes: 𝑓 0.0048 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0072 ( 54 hom. )

Consequence

CACNA1H
NM_021098.3 missense

Scores

5
12

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.994

Publications

9 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.014217705).
BP6
Variant 16-1213819-C-T is Benign according to our data. Variant chr16-1213819-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 96013.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00479 (729/152210) while in subpopulation NFE AF = 0.00806 (548/67982). AF 95% confidence interval is 0.0075. There are 2 homozygotes in GnomAd4. There are 344 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 729 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1HNM_021098.3 linkc.4817C>T p.Thr1606Met missense_variant Exon 27 of 35 ENST00000348261.11 NP_066921.2 O95180-1B3KQH9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1HENST00000348261.11 linkc.4817C>T p.Thr1606Met missense_variant Exon 27 of 35 1 NM_021098.3 ENSP00000334198.7 O95180-1
CACNA1HENST00000569107.6 linkc.4832C>T p.Thr1611Met missense_variant Exon 26 of 34 1 ENSP00000454990.2 H3BNT0
CACNA1HENST00000711493.1 linkc.4835C>T p.Thr1612Met missense_variant Exon 26 of 34 ENSP00000518778.1
CACNA1HENST00000565831.7 linkc.4799C>T p.Thr1600Met missense_variant Exon 26 of 34 1 ENSP00000455840.1 O95180-2
CACNA1HENST00000711450.1 linkc.4832C>T p.Thr1611Met missense_variant Exon 27 of 35 ENSP00000518762.1
CACNA1HENST00000564231.6 linkc.4817C>T p.Thr1606Met missense_variant Exon 27 of 35 1 ENSP00000457555.2 H3BUA8
CACNA1HENST00000638323.1 linkc.4778C>T p.Thr1593Met missense_variant Exon 27 of 35 5 ENSP00000492267.1 A0A1W2PR14
CACNA1HENST00000562079.6 linkc.4799C>T p.Thr1600Met missense_variant Exon 26 of 34 1 ENSP00000454581.2 H3BMW6
CACNA1HENST00000711438.1 linkc.4760C>T p.Thr1587Met missense_variant Exon 26 of 34 ENSP00000518754.1
CACNA1HENST00000711482.1 linkc.4817C>T p.Thr1606Met missense_variant Exon 27 of 36 ENSP00000518771.1
CACNA1HENST00000711485.1 linkc.4799C>T p.Thr1600Met missense_variant Exon 26 of 35 ENSP00000518774.1
CACNA1HENST00000711455.1 linkc.4817C>T p.Thr1606Met missense_variant Exon 27 of 36 ENSP00000518768.1
CACNA1HENST00000711483.1 linkc.4817C>T p.Thr1606Met missense_variant Exon 27 of 35 ENSP00000518772.1
CACNA1HENST00000711456.1 linkc.4817C>T p.Thr1606Met missense_variant Exon 27 of 34 ENSP00000518769.1
CACNA1HENST00000621827.2 linkn.4817C>T non_coding_transcript_exon_variant Exon 27 of 37 6 ENSP00000518766.1
CACNA1HENST00000637236.3 linkn.*769C>T non_coding_transcript_exon_variant Exon 26 of 34 5 ENSP00000492650.2 A0A1W2PS38
CACNA1HENST00000639478.1 linkn.4755C>T non_coding_transcript_exon_variant Exon 27 of 35 5 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000640028.1 linkn.*2668C>T non_coding_transcript_exon_variant Exon 27 of 35 5 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000711442.1 linkn.*4261C>T non_coding_transcript_exon_variant Exon 25 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.4799C>T non_coding_transcript_exon_variant Exon 26 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.4799C>T non_coding_transcript_exon_variant Exon 26 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.4894C>T non_coding_transcript_exon_variant Exon 27 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.4817C>T non_coding_transcript_exon_variant Exon 27 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.4817C>T non_coding_transcript_exon_variant Exon 27 of 36 ENSP00000518765.1
CACNA1HENST00000711484.1 linkn.4799C>T non_coding_transcript_exon_variant Exon 26 of 35 ENSP00000518773.1
CACNA1HENST00000711486.1 linkn.4817C>T non_coding_transcript_exon_variant Exon 27 of 37 ENSP00000518775.1
CACNA1HENST00000711487.1 linkn.4817C>T non_coding_transcript_exon_variant Exon 27 of 36 ENSP00000518776.1
CACNA1HENST00000711488.1 linkn.4876C>T non_coding_transcript_exon_variant Exon 26 of 35 ENSP00000518777.1
CACNA1HENST00000637236.3 linkn.*769C>T 3_prime_UTR_variant Exon 26 of 34 5 ENSP00000492650.2 A0A1W2PS38
CACNA1HENST00000640028.1 linkn.*2668C>T 3_prime_UTR_variant Exon 27 of 35 5 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000711442.1 linkn.*4261C>T 3_prime_UTR_variant Exon 25 of 34 ENSP00000518758.1

Frequencies

GnomAD3 genomes
AF:
0.00480
AC:
730
AN:
152092
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00142
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00301
Gnomad ASJ
AF:
0.000576
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00310
Gnomad FIN
AF:
0.00490
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00806
Gnomad OTH
AF:
0.00382
GnomAD2 exomes
AF:
0.00501
AC:
1010
AN:
201458
AF XY:
0.00519
show subpopulations
Gnomad AFR exome
AF:
0.00130
Gnomad AMR exome
AF:
0.00211
Gnomad ASJ exome
AF:
0.000762
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00435
Gnomad NFE exome
AF:
0.00797
Gnomad OTH exome
AF:
0.00667
GnomAD4 exome
AF:
0.00720
AC:
10312
AN:
1432216
Hom.:
54
Cov.:
31
AF XY:
0.00715
AC XY:
5073
AN XY:
709850
show subpopulations
African (AFR)
AF:
0.00112
AC:
37
AN:
32998
American (AMR)
AF:
0.00239
AC:
95
AN:
39740
Ashkenazi Jewish (ASJ)
AF:
0.00121
AC:
31
AN:
25626
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38438
South Asian (SAS)
AF:
0.00389
AC:
320
AN:
82284
European-Finnish (FIN)
AF:
0.00474
AC:
233
AN:
49164
Middle Eastern (MID)
AF:
0.00175
AC:
10
AN:
5730
European-Non Finnish (NFE)
AF:
0.00842
AC:
9250
AN:
1098810
Other (OTH)
AF:
0.00565
AC:
336
AN:
59426
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
520
1039
1559
2078
2598
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
350
700
1050
1400
1750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00479
AC:
729
AN:
152210
Hom.:
2
Cov.:
32
AF XY:
0.00462
AC XY:
344
AN XY:
74414
show subpopulations
African (AFR)
AF:
0.00142
AC:
59
AN:
41564
American (AMR)
AF:
0.00301
AC:
46
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.000576
AC:
2
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5116
South Asian (SAS)
AF:
0.00290
AC:
14
AN:
4830
European-Finnish (FIN)
AF:
0.00490
AC:
52
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00806
AC:
548
AN:
67982
Other (OTH)
AF:
0.00378
AC:
8
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
35
70
104
139
174
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00654
Hom.:
7
Bravo
AF:
0.00448
ESP6500AA
AF:
0.00195
AC:
8
ESP6500EA
AF:
0.00798
AC:
67
ExAC
AF:
0.00498
AC:
597
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Oct 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CACNA1H: BS2 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Sep 15, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
Aug 14, 2024
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 05, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Epilepsy, childhood absence, susceptibility to, 6;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Dec 10, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.099
BayesDel_addAF
Benign
-0.17
T
BayesDel_noAF
Uncertain
-0.020
CADD
Benign
20
DANN
Uncertain
0.98
DEOGEN2
Benign
0.26
T;.;.;.
Eigen
Benign
-0.35
Eigen_PC
Benign
-0.39
FATHMM_MKL
Benign
0.30
N
LIST_S2
Uncertain
0.88
D;D;D;.
MetaRNN
Benign
0.014
T;T;T;T
MetaSVM
Uncertain
0.47
D
PhyloP100
0.99
PrimateAI
Benign
0.42
T
PROVEAN
Benign
-2.0
N;.;N;N
REVEL
Uncertain
0.50
Sift
Benign
0.22
T;.;T;T
Sift4G
Benign
0.24
T;.;T;T
Polyphen
0.28
B;.;P;P
Vest4
0.57
MVP
0.89
ClinPred
0.013
T
GERP RS
3.9
Varity_R
0.086
gMVP
0.58
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs59286323; hg19: chr16-1263819; API